Vivo Capital, LLC Portfolio Holdings

Vivo Capital, LLC

  • $512 Million
  • Q4 2024

Vivo Capital, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $512 Million distributed in 40 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $106M, Geron Corp with a value of $96.4M, Terns Pharmaceuticals, Inc. with a value of $38.5M, Dyne Therapeutics, Inc. with a value of $26.3M, and Aclaris Therapeutics, Inc. with a value of $22M.

Examining the 13F form we can see an decrease of $171M in the current position value, from $683M to 512M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $512 Million
Healthcare: $512 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 40
  • Current Value $512 Million
  • Prior Value $683 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 4 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email